"We'll pay more for the earnings of the non-Covid companies if The Lancet publishes some good news from AstraZeneca's vaccine trial," the "Mad Money" host said.
from Business News https://ift.tt/2OCStqJ
Popular Posts
-
By Jack Schneider and Jennifer C. Berkshire from NYT Opinion https://ift.tt/3mlNqtX via IFTTT
-
(GRIDLEY, Calif.) — Authorities said Thursday that at least 10 people have died in a massive Northern California wildfire and 16 pe...
-
LONDON — First came the Brexit trade deal. Now comes the red tape and the institutional nitty gritty. Four days after sealing a fr...
-
By Marc Santora from NYT World https://ift.tt/a9DgGVR via IFTTT
-
Ready to go out on the town before summer ends? In parts of the U.S., you might have to carry your COVID-19 vaccine card or a digit...
-
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock question...
-
The move is a reminder of just how much the music industry has changed with the advent of streaming and social media, which have allowed art...
-
By Katherine Rosman from NYT Style https://ift.tt/3tPTKg0 via IFTTT
-
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock question...
-
U.S. Embassy in Kabul Tells Staff to Destroy Sensitive Material and Evacuate 57 by everybodyknows | 49 comments on Hacker News.
No comments:
Post a Comment